Low-Intensity Focused Ultrasound (LIFU) Neuromodulation

Part of paid clinical trials in Morgantown, West Virginia.

Sponsor
Ali Rezai
Study ID
NCT05997030
Status
Recruiting
Apply to this trial

Conditions

Eligibility Criteria

Sex
ALL
Age
45 Years - 85 Years
Healthy Volunteers
Not accepted

Interventions

  • low intensity focused ultrasound (LIFU) — DEVICE
    Subjects will undergo undergo a single LIFU of the target brain region

Study Details

This study is a prospective, single-center, single-arm early feasibility study, to establish safety and tolerability of LIFU for neuromodulation in patients with mild cognitive impairment ( MCI) due to Alzheimer's disease.

Key Dates

Start date
Oct 12, 2023
Status verified
Nov 2025
Primary completion
Sep 30, 2026
Completion
Sep 30, 2026

Study Design

Enrollment
15 participants (estimated)
Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT

Arms

  • Experimental: Neuromodulation
    Subjects meeting eligibility criteria will undergo Exablate low intensity focused ultrasound neuromodulation

Primary Outcome Measure

Occurrence of Treatment Emergent Adverse Events [ Time Frame: baseline and 7 and days after study procedure ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
Rockefeller Neuroscience Institute at West Virginia UniversityMorgantownWest Virginia26505
Marc W Haut, PhD
[email protected]
304-293-6276

Find similar trials in Morgantown, WV

By condition
Alzheimer's disease
By specialty
NeurologyDementia careBrain disordersGeriatrics
By research site
Rockefeller Neuroscience Institute at West Virginia University· Morgantown, WV

Related Studies